THE STATE OF REDOX HAEMOSTASIS IN PATIENTS WITH DYSHORMONAL BREAST DISEASES IN COMORBIDITY WITH GENITAL ENDOMETRIOSIS
DOI:
https://doi.org/10.11603/24116-4944.2023.2.14338Keywords:
redox haemostasis, dyshormonal diseases, mammary glands, comorbidity, genital endometriosis, oxidant-antioxidant systemAbstract
The aim of the study - is to assess the state of oxidant and antioxidant system in patients with dyshormonal breast diseases in comorbidity with genital endometriosis.
Materials and Methods. The study included 90 patients with dyshormonal breast diseases in comorbidity with genital endometriosis and 25 women in the control group. The patients were divided into three groups depending on the method of treatment: the first group consisted of 30 patients who received progesterone hormone therapy from day 11 to day 25 of the menstrual cycle for 3 months; the second group (30) received gonadotropin-releasing hormone agonists (a-GnRH) monthly for 3 menstrual cycles; the third group (30 patients) received our proposed treatment regimen with the use of gonadotropin-releasing hormone agonists monthly for 3 menstrual cycles with additional administration of Vitex agnus castus herb extract BNO 1095 and the antioxidant selenium active at a dose of 200 mg per day for three months. The study was conducted in accordance with current clinical protocols. BI-RADS Breast Imaging-Reporting and Data System is a standardised scale for assessing the results of mammography, ultrasound and MRI for the risk of breast cancer. To assess the intensity of free radical oxidation in patients, the content of diene conjugates (DC) was determined by the method of I.D. Stalnaya, malondialdehyde (MDA) by the method of I.D. Stalnaya and T.G. Garishvili. The activity of superdismutase (SDS) and glutathione reductase (GR) was studied spectrophotometrically at 340 nm.
Results and Discussion. After analysing the data obtained, complaints of lumping, increased volume, increased sensitivity and tenderness during breast palpation in the second phase of the menstrual cycle were observed in 88 (97.8 %) of the subjects. Infertility was the reason for the visit in 30 (33.3 %) patients and menstrual irregularities in 40 (44.4 %) patients. Changes in the mammary glands were determined by the BI-RADS scale. The analysis of the obtained data revealed that in patients with dyshormonal breast diseases in comorbidity with genital endometriosis, there is an increase in the activity of lipid peroxidation, as evidenced by an increase in the level of MDA and DC. The administration of the developed complex trapezoid allows to normalise the ratio of lipid peroxidation and antioxidant system.
Conclusions. It was found that in the plasma of patients of the study group there was an increase in the activity of lipid peroxidation and an decrease in the activity of glutathione reductase and a recurrent decrease in the activity of superoxide dismutase. The described changes are characteristic of metabolic acidosis and indicate a strain on adaptive capacities. The administration of the developed complex trapezoid allows to normalise the ratio of lipid peroxidation and antioxidant system.
References
Dotters-Katz, S.K., & Valea, F.A. (2021). Major Diseases in Which Menstrual Hormonal Changes Affect Symptoms. Comprehensive Gynecology. Elsevier. DOI: 10.1016/B978-0-323-65399-2.00017-6.
Al-Suhaimi, E.A., Khan, F.A., & Homeida, A.M. (2022). Regulation of Male and Female Reproductive Functions. Emerging Concepts in Endocrine Structure and Functions (pp. 287–347). DOI: 10.1007/978-981-16-9016-7_9.
Gottschau, M., Jensen, A., Reinholdt, K., Guleria, S., Munk, C., Mellemkjær, L., & Kjær, S.K. (2019). Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study. Breast Cancer Research and Treatment, 178(1), 199-205. DOI: 10.1007/s10549-019-05369-8.
Shurpyak, S.O. (2022). The substantiation of differentiated therapy of the combined disgormonal pathology of reproductive organs in women of reproductive age with comorbid conditions. Reproductive Health of Woman, 2022(4), 30-37. DOI: 10.30841/2708-8731.4.2022.262768.
Hine, A., Bowles, J., & Webber, T. (2023). The Need for a Non-Invasive Technology for Endometriosis Detection and Care. Studies in Health Technology and Informatics, 302, 103-107. DOI: 10.3233/SHTI230073.
Mullet, J., & Hagan-Aylor, C. (2013). Obstetrics and gynecology physicians. A critical part of the health care team for women with newly diagnosed breast cancer. Obstetrics and Gynecology Clinics of North America. DOI: 10.1016/j.ogc.2013.05.008.
Ussher, J. M., Chrisler, J. C., & Perz, J. (2019). Routledge international handbook of women’s sexual and reproductive health. Routledge International Handbook of Women’s Sexual and Reproductive Health, 1-614. DOI: 10.4324/9781351035620.
Roche, C., Chaffay, B., & Craig, C. (2023). Endocrinologic Emergencies. The Emergency Department Technician Handbook. DOI: 10.1016/B978-0-323-83002-7.00012-7.
Surya, B., & Ravivarman, G. (2019). A study of infections among rural women: Association of socio demographic factors with dyspareunia and abdominal pain. International Journal of Pharmaceutical Research, 11, 120-126.
Mitsopoulou, D., Papadopoulos, A., Papadopoulou-Skordou, E., Papathanasiou, A. A., Papapetrou, C., & Vlahos, N. (2021). Gender dysphoria in the field of obstetrics and gynecology. Med, 2(5), 475-481. DOI: 10.1016/j.medj.2021.04.024.
Rowlands, I.J., Mishra, G.D., & Abbott, J.A. (2022). Global Epidemiological Data on Endometriosis. Endometriosis and Adenomyosis: Global Perspectives Across the Lifespan. Springer International Publishing. DOI: 10.1007/978-3-030-97236-3_2.
Chlibovska, O.I., Boychuk, A.V., & Dzhyvak, V.H. (2015). Analysis of results of complex treatment of endometriozis of female genital organs. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1), 181-184. DOI: 10.11603/24116-4944.2015.1.4718.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Actual Problems of Pediatrics, Obstetrics and Gynecology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
